Novo Nordisk picks Doustdar as new CEO, shares plunge
Novo Nordisk named Maziar Mike Doustdar as its new chief executive today, relying on an experienced company insider to revive sales and a share price hit by worries the maker of weight-loss drug Wegovy is falling behind in a race it started.
Business
• 29 Jul
